Extracellular vesicle-derived non-coding RNAs in remodeling melanoma - 29/02/24
Abstract |
Melanoma is one of the most lethal cutaneous malignancies. Despite great advances in radiotherapy, chemotherapy, and immunotherapy, the survival rate and prognosis of patients with melanoma remain poor. The abundant and sophisticated reciprocal communication network between melanoma cells and non-tumor cells contributes to the high heterogeneity of the melanoma microenvironment and is intimately related to varying treatment responses and clinical courses. Extracellular vesicles (EVs) are membrane structures generated by nearly all cell types. EVs contain biologically active molecules, mainly comprising proteins, lipids, and RNAs, and undoubtedly play multifaceted roles in numerous diseases, represented by melanoma. Non-coding RNAs (ncRNAs) mainly encompass long non-coding RNAs, microRNAs, and circular RNAs and constitute the majority of the human transcriptome. Multiple ncRNAs encapsulated in EVs coordinate various pathophysiological processes in melanoma. This review summarizes the mechanisms by which EV-ncRNAs modulate biological behaviors and immunity, and their potential diagnostic and therapeutic applications in melanoma. Undoubtedly, further insight into EV-ncRNAs and their functions in melanoma will contribute to the clinical treatment of melanoma and the implementation of precision medicine.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Highlights |
• | EV-ncRNAs mediate melanoma resistance to drugs including Vemurafenib and the pharmacology for metformin with cisplatin. |
• | EV-ncRNAs are pivotal in reconfiguring the biological behavior of melanoma and participating in melanoma diagnosis. |
• | Multiple EV-ncRNAs derived from melanoma microenvironment participate in melanoma growth, metastasis, and Warburg effects. |
• | EV-ncRNAs can regulate the immune responses of melanoma by remodeling recipient immune cells. |
• | EV-ncRNAs in serum are promising biomarkers for liquid biopsy and possible therapeutic targets for melanoma. |
Abbreviations : aMT-exos, CAFs, circRNAs, CSCs, DCs, ECs, EMT, ERK, EVs, evPD-L1, IL2-sEVs, JAK2/STAT3, lncRNAs, MAPK, MAPKi, MDSCs, miRNAs, MPCs, MSCs, MVs, ncRNAs, OLs, OL-SCs, pEVs, PD-1, PD-L1, PI3K/AKT, POLs, PTPN7, sEVs, TNF-α, UM, UTR
Keywords : Melanoma, Extracellular vesicles, Non-coding RNAs, Immune regulation, Diagnosis, Therapy
Plan
Vol 172
Article 116213- mars 2024 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?